Information about Octimet Oncology
My details
*
*
*

Octimet Oncology (SA)

Company information

Status
Active

Enterprise number

BE0651.853.757

VAT liability
Yes
Established
12-04-2016
Last balance sheet year
2025
Company size
Micro 0 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Octimet Oncology

2025 2024 2023 2022
Profit/Loss -95,727 -153,24% 179,816 236,41% -131,817 9,99% -146,453
Equity 243,628 -28,21% 339,354 108,14% -4,168,239 -3,27% -4,036,423
Gross margin -16,540 70,61% -56,278 < -1000% 2,777 114,21% -19,537

Publications from Octimet Oncology

Date Publication
14-06-2024 Resignations - Appointments (NL)
07-03-2024 Modification(s) Articles of Association (NL)
19-02-2024 Resignations - Appointments (NL)
15-02-2024 Modification(s) Articles of Association (NL)
11-10-2023 Articles of Association (Translation, Coordination, Other Modifications, …) (NL)

Frequently asked questions

What is the VAT number of Octimet Oncology?
The VAT number of Octimet Oncology is BE 0651.853.757.
Wat is the PEPPOL ID of Octimet Oncology?
The PEPPOL ID of Octimet Oncology is 0208:0651853757. Log in or start a free trial to see the full overview.
When was Octimet Oncology founded?
Octimet Oncology was founded on 12-04-2016.
What is the address of Octimet Oncology?
The current registered office of Octimet Oncology is located at Oudepostelseweg 1, 2440 Geel.
When was the last time Octimet Oncology filed their annual financial statements?
The most recent financial statements of Octimet Oncology were filed on 25-07-2026.
How many employees does Octimet Oncology have?
There are currently no employees working at Octimet Oncology or no workforce information is available.
What is the annual turnover of Octimet Oncology?
At the time of its most recent financial statements, Octimet Oncology did not publish any turnover figures. Octimet Oncology reported a gross margin of -€16,539.54.